Botox During Hirschsprung's Pull-Through: Where the Field Stands
Carousel1 min read·Published Oct 2026

Botox During Hirschsprung's Pull-Through: Where the Field Stands

Title slide showing operating room illustration for carousel on botulinum toxin use in Hirschsprung surgery.
Poll results showing 50-50 split on Botox use in pull-through procedures with national benchmark of 24%.
Slide listing three unresolved clinical questions about botulinum toxin use in pediatric surgery with expert quote.
Title slide announcing a full breakdown video available via link in bio, sponsored by Cincinnati Children's.
1 / 5

Carousel · Oct 2026 · 1 min read

In brief

In brief

This carousel examines the current evidence and clinical practice surrounding botulinum toxin injection during pull-through procedures for Hirschsprung disease. Content reviews sphincter management strategies and postoperative outcome data to guide surgical decision-making in pediatric colorectal cases.

Written by the GCMD Library team from the carousel.

Slides

5 pages · click to turn to one

A clinical comparison chart displaying three treatment modalities in vertical columns with icons, percentage metrics, and outcome indicators. Each column uses distinct visual markers to represent different surgical techniques, with success rate percentages prominently displayed and complication data shown below. Color-coded sections differentiate efficacy metrics from safety profiles.

Hirschsprung disease. A social-media carousel made possible by Cincinnati Children's.
The text in the image

Pediatric Achalasia: Surgical Approach Comparison | Heller Myotomy | 78% Success Rate | Esophageal Dilatation | 45% Success Rate | POEM (Peroral Endoscopic Myotomy) | 99% Success Rate | 742 Cases Reviewed | Complication Rates | Training Requirements | Ambulation Outcomes | Neuroprotection | Clinical Selection Criteria

The text on each slide
  1. Made possible by Cincinnati Children's | THE PRACTICE PULSE | BOTOX DURING HIRSCHSPRUNG'S PULL-THROUGH? | The field is split — here's where it stands. | Swipe right
  2. Cincinnati Children's changing the outcome together | ⚡ WHERE THE FIELD STANDS | 📊 LIVE AUDIENCE POLL: | No Botox | 50% | Yes / Variable | 50% | National benchmark: A 2022 multicenter study found 24% of all pull-throughs include intrasphincteric Botox. | Swipe right
  3. Cincinnati Children's | WHAT WE'RE | EMERGING DATA: | Enterocolitis at 31 days post-pull-through: | 50% No Botox vs 30% With Botox | Cincinnati Children's, 2020-2024 | Trade-off: Patients receiving Botox had higher rates of diaper rash. | Annie Le-Nguyen, MD, MSc | Pediatric Surgeon, Pediatric Colon & Rectal Surgeon Fellow, Cincinnati Children's | Swipe right
  4. Cincinnati Children's | STILL UNRESOLVED | OPEN QUESTIONS: | Which botulinum toxin to use | No consensus across centers | How many units | Current practice: per-kg, max ~100u | Ultrasound guidance | Dr. Speck: yes, but requires training | "We need a little bit better data on this." | — Nelson Rosen, MD | Pediatric Surgeon, Cincinnati Children's | Swipe right
  5. Made possible by Cincinnati Children's changing the outcome together | FULL BREAKDOWN IN OUR LATEST VIDEO, LINK IN BIO! | GC
Try
Intelligent Search· scoped to this carousel · not medical adviceSearch the whole library →